Fecal Microbiota Transplantation & Ulcerative colitis
Fecal Microbiota Transplantation for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study.
Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis.
Fecal microbiota transplantation is a rescue treatment modality for refractory ulcerative colitis.
Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation.
[Ulcerative colitis: Does the modulation of gut microbiota induce long-lasting remission?].
AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.
Why is it so difficult to evaluate faecal microbiota transplantation as a treatment for ulcerative colitis?
Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
Efficacy of intestinal microbiota transplantation in ulcerative colitis: a review of current literature and knowledge.
Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.
Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.
New treatment strategies for ulcerative colitis.
Enteric microbiota leads to new therapeutic strategies for ulcerative colitis.
Low Level Engraftment and Improvement following a Single Colonoscopic Administration of Fecal Microbiota to Patients with Ulcerative Colitis.
Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis.
Protocol for a randomised, placebo-controlled pilot study for assessing feasibility and efficacy of faecal microbiota transplantation in a paediatric ulcerative colitis population: PediFETCh trial.
Coexisting cytomegalovirus infection in immunocompetent patients with Clostridium difficile colitis.
Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations.